BONESUPPORT Q3 2026: 38% Revenue Surge, Double‑Digit Profit Boost & US Market Expansion
Q3 2026 earnings: BONESUPPORT holding 38 % revenue lift, US‑driven growth, SOLARIO trial progress, and a share‑buyback signal high growth in orthobiologics.
2 minutes to read
